ONCOLOGY SOLUTIONS FOR ALL SAMPLE TYPES. Experts in FFPE AND LIQUID BIOPSIES
Your genomics partner in oncology
Answer any DNA and RNA related question
Research
Precision oncology
Clinical trials
Safety testing
Our GENOMICS Solutions for ONCOLOGY
We provide all the solutions you will need
Biomarkers
Precision oncology
Clinical trials
Immuno-Oncology
Safety testing
Read more
Helping to improve patients outcome by:
- Comprehensive genomic cancer profiling (CGP) of 591 cancer genes
- Exome sequencing (WES)
- Whole genome sequencing (WGS)
- Pharmacogenomics (PGx)
- Hotspot actionable variant genotyping (Oncotarget)
- Fusion transcripts and gene expression profiling
- Structural variant detection (SVs, CNVs)
- Liquid biopsy solutions
- Minimal residual disease (MRD)
- Companion diagnostics
- Kit development and logistics
Read more
All services are available GCP compliant:
- Inclusion criteria testing
- Pharmocogenetic services (PGx)
- Safety testing, e.g.: vector shedding, RCR, RCV, VCN, residual host cell DNA
- Adventitious virus testing
- Expression profiling and biomarker testing
- Logistic and central laboratory services
- Cell line authentication and mycoplasma check service
- Sanger, NGS, dPCR and qPCR services
- Quality control (QC) services
Read more
Determine the mutational status:
- Tumour mutational burden analyses (TMB)
- Micro satellite instability testing (MSI)
- Homologous recombination deficiency scoring (HRD)
- Copy number aberration burden (CNA burden)
- Neoantigen detection
- Utilising comprehensive genomic profiling, exome, genome and transcriptome sequencing
- Minimal residual disease (MRD) testing
- Liquid biopsy solutions
Read more
- Residual host cell DNA testing
- Adventitious virus testing
- Vector shedding, RCR, RCV, VCN testing
- Cell line authentication and mycoplasma check service
- Testing modified genomes (e.g.: CAR-T cells)
- GLP accredited solutions, GCP compliant services
- Toxicology screening solutions
Immuno-Oncology
Read more
Determine the mutational status:
- Tumour mutational burden analyses (TMB)
- Micro satellite instability testing (MSI)
- Homologous recombination deficiency scoring (HRD)
- Copy number aberration burden (CNA burden)
- Neoantigen detection
- Utilising comprehensive genomic profiling, exome, genome and transcriptome sequencing
- Minimal residual disease (MRD) testing
- Liquid biopsy solutions
Transcript and RNA
Read more
Profile you tumour sample for fusion transcripts, differential gene expression, splice variants and neoantigens with:
- Stranded library sequencing
- RNA Exome sequencing
- FFPE expression analysesUltra low amount RNA sequencing
- Whole transcriptome arrays and biobank screenings
- Single gene and marker expression testing
- miRNA profiling
Structural variants
Read more
Benefit from our unique comprehensive toolbox to detect:
- Chromosomal rearrangements
- Fusion genes
- Copy number variations (CNV)
- Telomeric aberrations
- Comparative genomic hybridization (CGH) Array
- Loss of heterozygosity (LOH)
- Insertions and Deletions
Biomarkers
Read more
Identification and follow up of biomarkers by:
- dPCR and qPCR assays
- Liquid biopsy services
- Actionable mutation panel (Oncotarget)
- Comprehensive genomic tumour profiling (Oncoprofiling – 591 genes)
- Ultra-high throughput and low cost expression profiling (GoScreen)
- SNP, CGH and expression microarrays
- Genome, exome and transcriptome sequencing
- Custom assay development
Safety testing
Read more
- Residual host cell DNA testing
- Adventitious virus testing
- Vector shedding, RCR, RCV, VCN testing
- Cell line authentication and mycoplasma check service
- Testing modified genomes (e.g.: CAR-T cells)
- GLP accredited solutions, GCP compliant services
- Toxicology screening solutions
Structural variants
Transcript and RNA
Liquid biopsy
Epigenetics
Beyond genomics
Read more
Benefit from our unique comprehensive toolbox to detect:
- Chromosomal rearrangements
- Fusion genes
- Copy number variations (CNV)
- Telomeric aberrations
- Comparative genomic hybridization (CGH) Array
- Loss of heterozygosity (LOH)
- Insertions and Deletions
Read more
Profile you tumour sample for fusion transcripts, differential gene expression, splice variants and neoantigens with:
- Stranded library sequencing
- RNA Exome sequencing
- FFPE expression analysesUltra low amount RNA sequencing
- Whole transcriptome arrays and biobank screenings
- Single gene and marker expression testing
- miRNA profiling
Read more
Understanding the cancer patient analysing cfDNA and CTC DNA from plasma, liquor and urine:
- Hotspot actionable variant genotyping (Oncotarget)
- Custom qPCR and dPCR assays
- Low pass whole genome sequencing
- Whole exome sequencing
- Comprehensive genomic cancer profiling (CGP) of 591 cancer genes
- Custom NGS panels
- Targeted bisulfite sequencing
- ThermoFisher and Illumina oncology arrays
Read more
Decode the epigenome in various ways:
- Genome wide methylation array (EPIC)
- Whole genome bisulfite sequencing (WGBS)
- Reduced representation bisulfite sequencing (RRBS)
- Target bisulfite sequencing from liquid biopsies
- Custom targeted assay development
Read more
Complete Eurofins group oncology service world:
- Pathology, histology, immunohistochemistry
- Cell line and compound testing
- CDMO service
- Biopharma product testing
- Central lab services
- Medical diagnostic laboratory service
Liquid biopsy
Read more
Understanding the cancer patient analysing cfDNA and CTC DNA from plasma, liquor and urine:
- Hotspot actionable variant genotyping (Oncotarget)
- Custom qPCR and dPCR assays
- Low pass whole genome sequencing
- Whole exome sequencing
- Comprehensive genomic cancer profiling (CGP) of 591 cancer genes
- Custom NGS panels
- Targeted bisulfite sequencing
- ThermoFisher and Illumina oncology arrays
Precision oncology
Read more
Helping to improve patients outcome by:
- Comprehensive genomic cancer profiling (CGP) of 591 cancer genes
- Exome sequencing (WES)
- Whole genome sequencing (WGS)
- Pharmacogenomics (PGx)
- Hotspot actionable variant genotyping (Oncotarget)
- Fusion transcripts and gene expression profiling
- Structural variant detection (SVs, CNVs)
- Liquid biopsy solutions
- Minimal residual disease (MRD)
- Companion diagnostics
- Kit development and logistics
Clinical trials
Read more
All services are available GCP compliant:
- Inclusion criteria testing
- Pharmocogenetic services (PGx)
- Safety testing, e.g.: vector shedding, RCR, RCV, VCN, residual host cell DNA
- Adventitious virus testing
- Expression profiling and biomarker testing
- Logistic and central laboratory services
- Cell line authentication and mycoplasma check service
- Sanger, NGS, dPCR and qPCR services
- Quality control (QC) services
Epigenetics
Read more
Decode the epigenome in various ways:
- Genome wide methylation array (EPIC)
- Whole genome bisulfite sequencing (WGBS)
- Reduced representation bisulfite sequencing (RRBS)
- Target bisulfite sequencing from liquid biopsies
- Custom targeted assay development
Beyond genomics
Read more
Complete Eurofins group oncology service world:
- Pathology, histology, immunohistochemistry
- Cell line and compound testing
- CDMO service
- Biopharma product testing
- Central lab services
- Medical diagnostic laboratory service
Full scalability
100%
From one to millions of samples.
Don’t be afraid to think big!
tackle your challenges
Our technologies
We provide everything you need:
- Next-generation sequencing (Illumina and Oxford Nanopore Technologies platforms)
- Microarrays (all Illumina and Thermo Fisher platforms)
- qPCR / dPCR
- Sanger sequencing
- Oligo synthesis
- Gene synthesis
- DNA / RNA extractions
- Assay design & validation
- Bioinformatics
- Bio-banking
- Sampling kits supply and logistics network
Express solutions
Make full use of our high capacities, high reliability, and fastest turnaround time
- 1 business day qPCR/dPCR biomarker testing
- 5 business days microarray service
- 9 business days exome
- 9 business days comprehensive genomic profiling
- 10 business days whole human genome
- Fastest logistics solutions
- Shortest response time
Quality is our second name
Work with a fully certified partner
ISO 17025
Read more
Guaranteed confidentiality and integrity of testing data.
Testing results are recognised by authorities and customs, etc. for the release of pharmaceuticals and food and feed, in the case of legal implications.
ISO 13485
Read more
Full documentation and traceability of production processes.
Compliance with regulatory requirements in regard to EU, US and other national directives about medical devices, in vitro Diagnostics or medicinal products.
Quality management system is in line with the FDA QSR standards.
ISO 9001
Read more
Short production times due to highly optimised and structured processes.
Well trained, competent and highly qualified personnel.
Fully documented processes.
Effective complaint and CAPA management.
GCLP
Read more
Guaranteed confidentiality and integrity of clinical trial data.
Full protection of patient rights, safety and well-being.
Full compliance with GCLP regulatory requirements.
Acceptance of clinical study data by regulatory authorities in EU, US and worldwide.
GLP
Read more
Full traceability of GLP study data.
GLP compliant archiving of study data and records.
Full compliance with GLP regulatory requirements (OECD, EMA, US-FDA, US-EPA).
Acceptance of non-clinical safety study data by regulatory authorities in EU, US and worldwide.
We are the one provider that covers all aspects of your project
Benefit from our large network of labs and technologies
Eurofins Genomics as part of Eurofins Scientific is a market leader in services for genomics, discovery pharmacology and clinical studies. With our globally unrivalled lab network, we support standard and challenging research projects, as well as complex strategies for large interdisciplinary companies.
We support from research to application:
Pharma | Diagnostics | Biotechnology
You are in good company – we are approved by our peers
Eurofins Genomics is a trusted brand
around the globe
We cooperate with 16 of the TOP 20 Big Pharma companies
We cooperate with renowned organisations ranging from small-, medium- and large-scale enterprises to academic institutions. We provide leading expertise and sequencing capabilities that are needed to address some of today’s most important scientific and technical challenges.
We are scientific partners with
We are cooperation partners with
We are scientific partners with
We are cooperation partners with
Your dedicated Oncology Expert
Bernhard Busch, PhD
Scientific Sales Representative
Interesting articels and webinars
Application of genomics solutions in oncology
Digital PCR
NGS AS CLINICAL DIAGNOSTICS TOOL IN ONCOLOGY
ONCOMPASS – TRUSTED PARTNER FOR PERSONALISED CANCER THERAPY
Cancer Ecology
dPCR is used in oncology and enables precise and sensitive cancer diagnostics. Find out how cfDNA in bodily fluids is used for cancer diagnostics by dPCR.
Genome analysis of cancers is used to choose the most effective cancer therapies, called personalised medicine. Learn how NGS is used in diagnostics for oncology.
Personalised cancer therapy is complicated and Oncompass provides navigation to decide for the best-suited therapy.
What do invasive species and metastasis have in common? What is the effect of selective pressure on cancer cells and how does this impact cancer therapy?
Digital PCR
dPCR is used in oncology and enables precise and sensitive cancer diagnostics. Find out how cfDNA in bodily fluids is used for cancer diagnostics by dPCR.
NGS AS CLINICAL DIAGNOSTICS TOOL IN ONCOLOGY
Genome analysis of cancers is used to choose the most effective cancer therapies, called personalised medicine. Learn how NGS is used in diagnostics for oncology.
ONCOMPASS – TRUSTED PARTNER FOR PERSONALISED CANCER THERAPY
Personalised cancer therapy is complicated and Oncompass provides navigation to decide for the best-suited therapy.
ONCOMPASS – TRUSTED PARTNER FOR PERSONALISED CANCER THERAPY
What do invasive species and metastasis have in common? What is the effect of selective pressure on cancer cells and how does this impact cancer therapy?
Festival of Genomics 2021 Webinar
Better than exomes
Better than panels. What are the relative genomic aberrations in tumours? Analyse virtually all cancer-associated genes with one solution: Comprehensive genomic cancer profiling.